NRAS and cutaneous melanoma: To identify therapeutic vulnerabilities in NRAS‐mutant melanoma, we explored different potential targets for expression in the TCGA skin cutaneous melanoma dataset (SKCM, Provisional 2017; http://www.cbioportal.org) (Cerami et al, 2012; Gao et al, 2013).